Vital Therapies reported $-19170000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Dynavax Technologies DVAX:US $ 9.68M 19.34M
Epizyme EPZM:US $ -58231000 6.11M
Insmed INSM:US $ -88566000 4.73M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Omeros OMER:US $ -24016000 6.6M
Orasure Technologies OSUR:US $ 1.58M 8.04M
Quidel QDEL:US $ 24.33M 200.58M
Revance Therapeutics RVNC:US $ -70337000 325K
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
United Therapeutics UTHR:US $ 222.2M 263.9M
Vital Therapies VTL:US $ -19170000 13.22M
Xoma XOMA:US $ -3064000 3.36M